Literature DB >> 9820422

Lower gastrointestinal bleeding as the initial presenting symptom of renal cell carcinoma.

V M Perez1, G J Huang, P W Musselman, D Chung.   

Abstract

Renal cell carcinoma is known as one of the "great mimics encountered in clinical medicine," along with syphilis and tuberculosis. It can present clinically as a wide range of symptoms, with a classic triad described as hematuria, pain, and a palpable abdominal mass. However, this triad is present only in <20% of patients with renal cell carcinoma. Gastrointestinal bleeding has been described in renal cell carcinoma, although mainly secondary to metastasis in the upper gastrointestinal tract, with few cases due to local invasion. Lower gastrointestinal bleeding as a presenting symptom of an invasive primary renal cell carcinoma has been described in only one patient in the literature. Our patient is the first in whom a colonoscopic biopsy was used as a successful diagnostic modality.

Entities:  

Mesh:

Year:  1998        PMID: 9820422     DOI: 10.1111/j.1572-0241.1998.00643.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  Locally advanced renal cell carcinoma: cause of upper gastrointestinal bleeding.

Authors:  Sarthak Soin; Eugene Verkhovsky
Journal:  BMJ Case Rep       Date:  2019-04-11

2.  Metastatic renal cell carcinoma mimicking diverticulitis in a patient with chronic lymphocytic leukaemia.

Authors:  S M Hwang; J M Kuyava; J P Grande; K M Swetz
Journal:  BMJ Case Rep       Date:  2015-01-07

3.  Upper gastro-intestinal bleeding - Rare presentation of renal cell carcinoma.

Authors:  Punit Tiwari; Astha Tiwari; Mukesh Vijay; Suresh Kumar; A K Kundu
Journal:  Urol Ann       Date:  2010-09

Review 4.  Metastases from renal cell carcinoma presenting as gastrointestinal bleeding: two case reports and a review of the literature.

Authors:  Gareth J Sadler; Mark R Anderson; Mark S Moss; Paul G Wilson
Journal:  BMC Gastroenterol       Date:  2007-01-31       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.